中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [9]
合肥物质科学研究院 [3]
中国科学院大学 [2]
自动化研究所 [2]
上海营养与健康研究所 [2]
深圳先进技术研究院 [1]
更多
采集方式
OAI收割 [20]
iSwitch采集 [2]
内容类型
期刊论文 [21]
学位论文 [1]
发表日期
2024 [1]
2022 [1]
2021 [4]
2020 [3]
2019 [1]
2018 [3]
更多
学科主题
筛选
浏览/检索结果:
共22条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
发表日期升序
发表日期降序
题名升序
题名降序
作者升序
作者降序
Synthesis and Biological Evaluation of β-Lactam Derivatives Targeting Speckle-Type POZ Protein (SPOP)
期刊论文
OAI收割
ACS MEDICINAL CHEMISTRY LETTERS, 2024, 卷号: 15, 期号: 2, 页码: 270-279
作者:
Zhou, Chenmao
;
Hao, Xinyue
;
Chen, Zhengyang
;
Zhang, Runze
;
Zhou, Qian
  |  
收藏
  |  
浏览/下载:19/0
  |  
提交时间:2024/03/13
Speckle-type POZ protein (SPOP)
SPOP inhibitors
Clear cell renal cell carcinoma (ccRCC)
Structure-activityrelationship (SAR)
Identification of ST3GAL5 as a prognostic biomarker correlating with CD8(+) T cell exhaustion in clear cell renal cell carcinoma
期刊论文
OAI收割
FRONTIERS IN IMMUNOLOGY, 2022, 卷号: 13, 页码: 14
作者:
Liu, Jiakuan
;
Li, Meiqian
;
Wu, Jiajun
;
Qi, Qi
;
Li, Yang
  |  
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2022/11/11
sialylation
clear cell renal cell carcinoma
ST3GAL5
CD8(+) T cell exhaustion
prognostic biomarker
Differentiation of renal angiomyolipoma without visible fat from small clear cell renal cell carcinoma by using specific region of interest on contrast-enhanced CT: a new combination of quantitative tools
期刊论文
OAI收割
CANCER IMAGING, 2021, 卷号: 21
作者:
Wang, Xu
;
Song, Ge
;
Jiang, Haitao
  |  
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2021/08/31
Down-regulation of BCL2L13 renders poor prognosis in clear cell and papillary renal cell carcinoma
期刊论文
OAI收割
CANCER CELL INTERNATIONAL, 2021, 卷号: 21
作者:
Meng, Fei
;
Zhang, Luojin
;
Zhang, Mingjun
;
Ye, Kaiqin
;
Guo, Wei
  |  
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2021/08/31
BCL-rambo
Cell death
Renal cancer
Prognosis
ANT
Can texture analysis based on single unenhanced CT accurately predict the WHO/ISUP grading of localized clear cell renal cell carcinoma?
期刊论文
OAI收割
ABDOMINAL RADIOLOGY, 2021
作者:
Wang, Xu
;
Song, Ge
;
Jiang, Haitao
;
Zheng, Linfeng
;
Pang, Peipei
  |  
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2021/06/15
Texture analysis
Clear cell renal cell carcinoma
Pathological nuclear grade
Computed tomography
PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma
期刊论文
OAI收割
THERANOSTICS, 2021, 卷号: 11, 期号: 11, 页码: 5387-5403
作者:
Wang, Jianfeng
;
Wang, Chen
;
Xu, Pan
;
Li, Xiao
;
Lu, Yongning
  |  
收藏
  |  
浏览/下载:77/0
  |  
提交时间:2021/05/24
clear cell renal cell carcinoma
protein arginine methyltransferase 1
therapeutic
lipocalin2 (LCN2)
sunitinib
Multiparametric MRI Radiomic Model for Preoperative Predicting WHO/ISUP Nuclear Grade of Clear Cell Renal Cell Carcinoma
期刊论文
OAI收割
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2020, 页码: 10
作者:
Li, Qiong
;
Liu, Yu-jia
;
Dong, Di
;
Bai, Xu
;
Huang, Qing-bo
  |  
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2020/06/22
renal cell carcinoma
nuclear grade
radiomic
magnetic resonance imaging
Development and External Validation of Radiomics Approach for Nuclear Grading in Clear Cell Renal Cell Carcinoma
期刊论文
OAI收割
ANNALS OF SURGICAL ONCOLOGY, 2020, 页码: 9
作者:
Zhou, Hongyu
;
Mao, Haixia
;
Dong, Di
;
Fang, Mengjie
;
Gu, Dongsheng
  |  
收藏
  |  
浏览/下载:42/0
  |  
提交时间:2020/06/22
Identification of an immune-related risk signature for predicting prognosis in clear cell renal cell carcinoma
期刊论文
OAI收割
AGING-US, 2020, 卷号: 12, 期号: 3, 页码: 2302-2332
作者:
Hua, Xiaoliang
;
Chen, Juan
;
Su, Yang
;
Liang, Chaozhao
  |  
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2020/04/23
clear cell renal cell carcinoma
gene signature
prognostic model
immune-related gene
tumor immunology
Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas
期刊论文
OAI收割
BMC CANCER, 2019, 卷号: 19, 期号: 1, 页码: 13
作者:
Zhang, Qing
;
Liu, Jian-He
;
Liu, Jing-Li
;
Qi, Chun-Ting
;
Yan, Lei
  |  
收藏
  |  
浏览/下载:65/0
  |  
提交时间:2020/07/01
Receptor tyrosine kinases (RTKs)
Activation and function
Clear cell renal cell carcinomas (ccRCCs)
Targeted therapy
PDGFR beta
Stroma cells